Skip to main content Skip to search Skip to main navigation

Swissmedic: Data on imports of illegal medicinal products via the internet

On 4 March 2021, Swissmedic announced the numbers on medicinal products illegally imported into Switzerland. In 2020, 6733 illegal imports were recorded. Compared to the previous year, the number has decreased only slightly.  Among the countries of origin, Singapore has replaced India, which has long been in the lead. It was followed by Western European countries such as the UK and Germany in particular.

Singapore is increasingly being used as a hub by suppliers of illegal medicinal products.

Which falsified medicinal products represent the majority?

Erectile stimulants continue to top the list, followed by other prescriptive medicinal products as well as sleeping pills and tranquilizers such as Xanax and Valium.

Swissmedic also warns against supposedly herbal products that, however, contain undeclared chemical active ingredients. They are advertised, especially in social media, as "herbal" and "natural" products for potency enhancement or for weight loss. Delivery often comes without a patient information leaflet or cardboard packaging.

A suspicion of an illegal drug should be reported to Swissmedic via the Medicrime contact form.

Successes in the fight against falsified medicinal products

In October 2020, German customs and the Bavarian Cybercrime Central Office succeeded in smashing a global network of illegally operating dealers in the "Hydra" investigation complex. Two people were arrested in the process. The international investigation lasted almost two years. The falsified preparations were assembled in a warehouse in Singapore, shipped by mail and sent by air freight.


Sources:

Swissmedic: Illegal imports of medicinal products in 2020: medicines from the internet are still in demand

Attorney General's Office Bamberg: Zoll und ZCB zerschlagen im Ermittlungskomplex „Hydra“ weltweites Netzwerk von Händlern illegaler und nicht zugelassener Arzneimittel – Zwei Haftbefehle vollstreckt (in German)

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

What should be considered in risk assessment?

What should be considered in risk assessment?

You can view the answer here:
Read more
 Basics on the Integrity of Container Closure Systems

Basics on the Integrity of Container Closure Systems

The integrity of a primary packaging system (container closure system) is essential to prevent product loss by leakage or evaporation and at the same time protect the product from contamination. The task of a primary packaging system (container closure system) is essentially to prevent the product from being lost (e.g. leakage, evaporation, etc.) and to prevent the product from being contaminated from the outside.

Read more
PAT CONNECT 2026: Register now!

PAT CONNECT 2026: Register now!

Read more
Swissmedic: Digital Package Leaflet Instead of Paper

Swissmedic: Digital Package Leaflet Instead of Paper

From 1 December 2025, medicines intended solely for use by healthcare professionals no longer require a printed package leaflet. Instead, a QR code on the outer packaging must provide direct access to the professional information.

Read more
EMA: 6 New Nitrosamines for Appendix 1

EMA: 6 New Nitrosamines for Appendix 1

Appendix 1 of EMA’s Questions and Answers on nitrosamine impurities has been updated. This appendix contains acceptable intakes (AIs) established for N-nitrosamines.

Read more
EU: First Four EUDAMED Modules Mandatory from 28 May 2026

EU: First Four EUDAMED Modules Mandatory from 28 May 2026

With Commission Decision (EU) 2025/2371, the European Commission has formally declared that the first four EUDAMED modules meet the required functional specifications. Publication in the OJEU on 27 November 2025 activates the six-month transition period foreseen in Regulation (EU) 2024/1860.

Read more
Previous
Next